Overview of a HLA-Ig based "lego-like system" for T cell monitoring, modulation and expansion

  • Oelke M
  • Schneck J
  • 38


    Mendeley users who have this article in their library.
  • 17


    Citations of this article.


Recent advances in molecular medicine have shown that soluble MHC-multimers can be valuable tools for both analysis and modulation of antigen-specific immune responses in vitro and in vivo. In this review, we describe the use of dimeric human and mouse major histocompatibility complexes, MHC-Ig, as part of an artificial Antigen-Presenting Cell (aAPC). MHC-Ig-based aAPC and its derivatives represent an exciting new platform technology for measuring and manipulating immune responses in vitro as well as in vivo. This new technology has the potential to help overcome many of the obstacles associated with limitations in current antigen-specific approaches of immunotherapy for the treatment of cancer, infectious diseases and autoimmunity.

Author-supplied keywords

  • Active and adoptive immunotherapy
  • CD8+CTL
  • Class I HLA
  • HLA-Ig dimer
  • Infectious diseases
  • Tumors

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Mathias Oelke

  • Jonathan P. Schneck

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free